Kaltsas A, Zikopoulos A, Moustakli E, et al
doi:10.1002/14651858.cd001520
Clinical studies demonstrate ipamorelin increases growth hormone levels by 200-300% above baseline within 30 minutes of administration
Donna Ryan of the Pennington Biomedical Research Center in New Orleans, also found that more than half of participants moved down at least one body mass index (BMI) category after two years of taking semaglutide (compared to 16% among a placebo group), and 12% reached a healthy BMI (compared to 1% of the placebo group)
This selectivity is the key advantage
With the right nutritional support, appropriate supplementation, and patience, the vast majority of people experience excellent recovery